Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Deferred Taxes of $71000.0 for Q1 2026, up 162.83% year-over-year from $27013.5 in Q1 2025, and down 56.44% quarter-over-quarter from $163000.0 in Q4 2025.
Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics' Deferred Taxes history runs 4 years deep, the most recent figure standing at $71000.0 for Q1 2026.
- In Q1 2026, Deferred Taxes rose 162.83% year-over-year to $71000.0; the TTM figure through Mar 2026 stood at $524000.0 (up 100.77% YoY), while the FY2025 annual figure was $340000.0, up 44.07% from the prior year.
- Deferred Taxes for Q1 2026 stood at $71000.0, down from $163000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $443000.0 in Q3 2024, with the low at -$3.1 million in Q2 2023.
- The 4-year median for Deferred Taxes is $48500.0 (2023), against an average of -$244500.0.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes jumped 1065.79% in 2024, then sank 86.68% in 2025.
- Protalix BioTherapeutics' Deferred Taxes stood at $38000.0 in 2023, then surged by 1065.79% to $443000.0 in 2024, then slumped by 63.21% to $163000.0 in 2025, then tumbled by 56.44% to $71000.0 in 2026.
- Business Quant data shows PLX's Deferred Taxes at $71000.0 in Q1 2026, $163000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.66 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | -3.13 Mn |